| NCT Number | NCT06095063 |
| Lead Sponsor | Rotman Research Institute at Baycrest
Collaborators: Brainsway, Centre for Addiction and Mental Health |
| Conditions | Alzheimer Disease, Subjective Cognitive Decline |
| Enrollment | 30 participants |
| Start Date | 2023-11-15 |
| Primary Completion | 2026-10-01 (estimated) |
| Study Completion | 2026-11-15 (estimated) |
| Updated on ClinicalTrials.gov | 2025-10-27 |